Literature DB >> 33454965

Neural cell-derived plasma exosome protein abnormalities implicate mitochondrial impairment in first episodes of psychosis.

Edward J Goetzl1,2, Vinod H Srihari3, Sinan Guloksuz3,4, Maria Ferrara3, Cenk Tek3, George R Heninger3.   

Abstract

Neuroprotective and other functional proteins of mitochondria were quantified in extracts of plasma neural-derived exosomes from ten first-episode psychosis (FP) patients and ten matched psychiatrically normal controls (ctls). Astrocyte-derived extracellular vesicles (ADEVs) and neuron-derived extracellular vesicles (NDEVs) were immunoabsorbed separately from physically precipitated plasma total EVs. Extracted mitochondrial ATP synthase was specifically immunofixed to plastic wells for quantification of catalytic activity based on conversion of NADH to NAD+ . Other extracted mitochondrial functional proteins were quantified by ELISAs. All protein levels were normalized with EV content of the CD81 exosome marker. FP patient ADEV level but not NDEV level of mitochondrial ATP synthase activity was significantly lower than that of ctls. FP patient ADEV and NDEV levels of the functionally critical mitochondrial proteins mitofusin 2 and cyclophilin D, but not of transcription factor A of mitochondria, and of the mitochondrial short open-reading frame neuroprotective and metabolic regulatory peptides humanin and MOTS-c were significantly lower than those of ctls. In contrast, FP patient NDEV, but not ADEV, level of the mitochondrial-tethering protein syntaphilin, but not of myosin VI, was significantly higher than that of ctls. The distinctively different neural levels of some mitochondrial proteins in FP patients than ctls now should be correlated with diverse clinical characteristics. Drugs that increase depressed levels of proteins and mimetics of deficient short open-reading frame peptides may be of therapeutic value in early phases of schizophrenia.
© 2021 Federation of American Societies for Experimental Biology.

Entities:  

Keywords:  ATP synthase; MOTS-c; cyclophilin D; humanin; mitofusin 2; schizophrenia

Mesh:

Substances:

Year:  2021        PMID: 33454965     DOI: 10.1096/fj.202002519R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  4 in total

1.  Abnormal levels of mitochondrial Ca2+ channel proteins in plasma neuron-derived extracellular vesicles of early schizophrenia.

Authors:  Edward J Goetzl; Vinod H Srihari; Maja Mustapic; Dimitrios Kapogiannis; George R Heninger
Journal:  FASEB J       Date:  2022-08       Impact factor: 5.834

Review 2.  Exosomes in schizophrenia: Pathophysiological mechanisms, biomarkers, and therapeutic targets.

Authors:  Yu Wang; Nousayhah Amdanee; Xiangrong Zhang
Journal:  Eur Psychiatry       Date:  2022-09-09       Impact factor: 7.156

3.  SARS-CoV-2 and Mitochondrial Proteins in Neural-Derived Exosomes of COVID-19.

Authors:  Michael J Peluso; Steven G Deeks; Maja Mustapic; Dimitrios Kapogiannis; Timothy J Henrich; Scott Lu; Sarah A Goldberg; Rebecca Hoh; Jessica Y Chen; Enrique O Martinez; J Daniel Kelly; Jeffrey N Martin; Edward J Goetzl
Journal:  Ann Neurol       Date:  2022-03-30       Impact factor: 11.274

Review 4.  New Insights Regarding Diagnosis and Medication for Schizophrenia Based on Neuronal Synapse-Microglia Interaction.

Authors:  Naotaka Izuo; Atsumi Nitta
Journal:  J Pers Med       Date:  2021-05-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.